A beta-cell specific global approach for drug identification in Type 2 Diabetes
Sithara, Smithamol 2018, A beta-cell specific global approach for drug identification in Type 2 Diabetes, Ph.D thesis, School of Medicine, Deakin University.
Type 2 Diabetes is a major health burden world-wide and current treatments cannot stop or slow the progression of this serious disease. This project created a novel drug development approach to identify drugs that can slow, stop or even prevent diabetes.
Language
eng
Indigenous content
off
Field of Research
060405 Gene Expression (incl Microarray and other genome-wide approaches) 111601 Cell Physiology
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO.
If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.